Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Junichi Takada, Rajani Dinavahi, Akimitsu Miyauchi, Etsuro Hamaya, Toshiyasu Hirama, Cesar Libanati, Yoichi Nakamura, Cassandra E. Milmont, Andreas Grauer

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences